General Information of Drug Therapeutic Target (DTT) (ID: TTE5VI6)

DTT Name Sphingomyelin phosphodiesterase 2 (SMPD2)
Synonyms SMPD2; Neutral sphingomyelinase; NSMase; N-SMase; Lyso-platelet activating factor-phospholipase C; Lyso-PAF-PLC
Gene Name SMPD2
DTT Type
Literature-reported target
[1]
BioChemical Class
Phosphoric diester hydrolase
UniProt ID
NSMA_HUMAN
TTD ID
T57316
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
EC 3.1.4.12
Sequence
MKPNFSLRLRIFNLNCWGIPYLSKHRADRMRRLGDFLNQESFDLALLEEVWSEQDFQYLR
QKLSPTYPAAHHFRSGIIGSGLCVFSKHPIQELTQHIYTLNGYPYMIHHGDWFSGKAVGL
LVLHLSGMVLNAYVTHLHAEYNRQKDIYLAHRVAQAWELAQFIHHTSKKADVVLLCGDLN
MHPEDLGCCLLKEWTGLHDAYLETRDFKGSEEGNTMVPKNCYVSQQELKPFPFGVRIDYV
LYKAVSGFYISCKSFETTTGFDPHRGTPLSDHEALMATLFVRHSPPQQNPSSTHGPAERS
PLMCVLKEAWTELGLGMAQARWWATFASYVIGLGLLLLALLCVLAAGGGAGEAAILLWTP
SVGLVLWAGAFYLFHVQEVNGLYRAQAELQHVLGRAREAQDLGPEPQPALLLGQQEGDRT
KEQ
Function
Converts sphingomyelin to ceramide. Hydrolyze 1-acyl-2- lyso-sn-glycero-3-phosphocholine (lyso-PC) and 1-O-alkyl-2-lyso- sn-glycero-3-phosphocholine (lyso-platelet-activating factor). The physiological substrate seems to be Lyso-PAF.
KEGG Pathway
Sphingolipid metabolism (hsa00600 )
Metabolic pathways (hsa01100 )
Sphingolipid signaling pathway (hsa04071 )
Reactome Pathway
Ceramide signalling (R-HSA-193681 )
TNFR1-mediated ceramide production (R-HSA-5626978 )
Glycosphingolipid metabolism (R-HSA-1660662 )

References

1 Neutral sphingomyelinase as a target for drug design. Drug News Perspect. 2001 Dec;14(10):581-90.